TrialScientific reports2022

FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain.

Diane M Bogdan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.